Works matching IS 01145916 AND DT 2025 AND VI 48 AND IP 7

Results: 11

Authors' reply to Chaker Ben Salem's comment on: "Drug-Induced Cognitive Impairment".

Published in:

Drug Safety, 2025, v. 48, n. 7, p. 841, doi. 10.1007/s40264-025-01568-z

By:

Reimers, Arne;
Odin, Per;
Ljung, Hanna

Publication type:

Article

Using Mixed Methods to Evaluate Risk Minimisation Programs in Europe and the USA: An Innovative Blueprint.

Published in:

Drug Safety, 2025, v. 48, n. 7, p. 821, doi. 10.1007/s40264-025-01533-w

By:

Smith, Meredith Y.;
Davis, Rachel;
Bahri, Priya;
Saragoussi, Delphine;
Nguyen, Viviana;
Toyserkani, Gita A.;
Hamilton, Alison

Publication type:

Article

REMS Logic Model: A Pragmatic Framework for Incorporating Drug Safety into Clinical Practice.

Published in:

Drug Safety, 2025, v. 48, n. 7, p. 715, doi. 10.1007/s40264-025-01542-9

By:

Toyserkani, Gita A.;
Robottom, Suzanne B.;
Morrato, Elaine H.

Publication type:

Article

The Frequency of Drug-Induced Liver Injury Due to Antibiotics Among Hospitalised Patients.

Published in:

Drug Safety, 2025, v. 48, n. 7, p. 795, doi. 10.1007/s40264-025-01541-w

By:

Björnsson, Robert A;
Sigurdsson, Sigurdur Sölvi;
Arnarson, Dagur Tjörvi;
Logason, Egill;
Björnsson, Einar Stefan

Publication type:

Article

Mitigation and Management of Common Toxicities Associated with the Administration of CAR-T Therapies in Oncology Patients.

Published in:

Drug Safety, 2025, v. 48, n. 7, p. 719, doi. 10.1007/s40264-025-01538-5

By:

Renninger, Jonathan;
Kurz, Lisa;
Stein, Heather

Publication type:

Article

Understanding the Work of the Pharmacovigilance Risk Assessment Committee (PRAC): A Quantitative Review of the Post-Authorisation Safety Evaluation of Antidiabetic Drugs from 2012 to 2022.

Published in:

Drug Safety, 2025, v. 48, n. 7, p. 781, doi. 10.1007/s40264-025-01536-7

By:

Le, Haoxin;
Sindahl, Per;
Andersen, Morten;
Hallgreen, Christine E.

Publication type:

Article

Comment on "Drug-Induced Cognitive Impairment".

Published in:

Drug Safety, 2025, v. 48, n. 7, p. 839, doi. 10.1007/s40264-025-01567-0

By:

Ben Salem, Chaker

Publication type:

Article

Off-the-Shelf Large Language Models for Causality Assessment of Individual Case Safety Reports: A Proof-of-Concept with COVID-19 Vaccines.

Published in:

Drug Safety, 2025, v. 48, n. 7, p. 805, doi. 10.1007/s40264-025-01531-y

By:

Abate, Andrea;
Poncato, Elisa;
Barbieri, Maria Antonietta;
Powell, Greg;
Rossi, Andrea;
Peker, Simay;
Hviid, Anders;
Bate, Andrew;
Sessa, Maurizio

Publication type:

Article

Narrative Search Engine for Case Series Assessment Supported by Artificial Intelligence Query Suggestions.

Published in:

Drug Safety, 2025, v. 48, n. 7, p. 767, doi. 10.1007/s40264-025-01529-6

By:

Zekarias, Alem;
Meldau, Eva-Lisa;
Bista, Shachi;
Félix China, Joana;
Sandberg, Lovisa

Publication type:

Article

Stakeholders' Perspectives Toward the Use of Patient Registry Data for Decision-Making on Medicines: A Cross-Sectional Survey.

Published in:

Drug Safety, 2025, v. 48, n. 7, p. 753, doi. 10.1007/s40264-025-01528-7

By:

Windfuhr, Fabian;
de Vries, Sieta T.;
Melinder, Maria;
Dahlqvist, Tanja;
Almeida, Diogo;
Sepodes, Bruno;
Torre, Carla;
Wettermark, Björn;
Mol, Peter G. M.

Publication type:

Article

QT Interval, Antipsychotics and Correlates Among Patients with Schizophrenia: Cross-Sectional Data from the Multicentric Real-World FACE-SZ.

Published in:

Drug Safety, 2025, v. 48, n. 7, p. 739, doi. 10.1007/s40264-025-01526-9

By:

Gerentes, Mona;
Lajnef, Mohamed;
Szöke, Andrei;
Aouizerate, Bruno;
Berna, Fabrice;
Cléry, Maud;
Chéreau, Isabelle;
Coulon, Nathalie;
Clauss-Kobayashi, Julia;
Fakra, Eric;
Dorey, Jean-Michel;
Dubertret, Caroline;
Fond, Guillaume;
Godin, Ophélia;
Goze, Tudi;
Lançon, Christophe;
Leboyer, Marion;
Leignier, Sylvain;
Llorca, Pierre-Michel;
Mallet, Jasmina

Publication type:

Article